CRT 2025

LATE-BREAKING CLINICAL TRIALS | STRUCTURAL AND LAA

Moderator(s)

• 

  Samir R. Kapadia, MD, FSCAI

  Chairman, Cardiovascular Medicine
  Cleveland Clinic
  Cleveland, Ohio, United States

  Disclosure(s): No financial relationships to disclose
• 

  Ron Waksman, MD, MSCAI

  Director, Cardiovascular Research and Advanced Education
  MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
  Washington, District of Columbia, United States

  Disclosure(s): Abbott Vascular: Grant/Research Support (Ongoing); Biotronik: Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Chiesi USA: Grant/Research Support (Ongoing)

Panelist(s)

• 

  Gregory P. Fontana, MD

  Director, CardioVascular Institute
  Hospital Corporation of America
  Thousand oaks, United States

  Disclosure(s): 4C Medical Technologies, Inc.: Grant/Research Support (Ongoing); Abbott: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences LLC: Grant/Research Support (Ongoing); Emblock: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); PiCardia: Grant/Research Support (Ongoing)
• 

  Danny Dvir, MD

  MD
  SZMC, Israel

  Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consultant (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing); Pi-Cardia: Consultant (Ongoing)
• 

  Nicolas M. Van Mieghem, MD, PhD, FESC, FACC

  Professor and Clinical Director of Interventional cardiology
  Thoraxcenter
  Rotterdam, Zuid-Holland, Netherlands

  Disclosure(s): Abbott Medical NL BV: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing); Adjust Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Alleviant Medial Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); AncorValve: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Approxima Srl: Consulting Fees (e.g., advisory boards) (Ongoing); Bolt Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo: Consulting Fees (e.g., advisory boards) (Ongoing); Ladera: Consulting Fees (e.g., advisory boards) (Ongoing); LUMA Vision: Consulting Fees (e.g., advisory boards) (Ongoing); Materialise: Consulting Fees (e.g., advisory boards) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Pie Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Polares: Consulting Fees (e.g., advisory boards) (Ongoing); PulseCath BV: Consulting Fees (e.g., advisory boards) (Ongoing); Secure Closure: Consulting Fees (e.g., advisory boards) (Ongoing); Siemens: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex: Grant/Research Support (Ongoing); Vivasure: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Bruce J. Rutkin, MD

  Director of Structural Heart Disease
  Northwell Health
  Manhasset, New York, United States

  Disclosure(s): Abbott Vascular,: Consultant (Ongoing); Edwards Lifesciences: Consultant (Ongoing); Medtronic Inc: Consultant (Ongoing)
• 

  Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI

  Professor of Cardiology and Population Health Science and Policy, Mount Sinai Endowed Professor in Cardiovascular Clinical Research and Outcomes; Director of Interventional Cardiovascular Research and Clinical Trials; Director of Women’s Heart and Vascular Center at Mount Sinai Heart
  Icahn School of Medicine at Mount Sinai, New York
  New York, New York, United States

  Disclosure(s): Abbott, Alleviant Medical, Beth Israel Deaconess Medical Center, Concept Medical, Cordis, Elixir Medical, Faraday Pharmaceuticals, Idorsia Pharmaceuticals, Janssen, MedAlliance, Mediasphere Medical, Medtronic, Novartis, Protembis GmbH, Sanofi, RM Glo: Grant/Research Support (Ongoing); AMA - JAMA Cardiology (Associate Editor), ACC (BOT Member, SC Member CTR Program): Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Elixir Medical, Stel, ControlRad (spouse): Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Elixir Medical, IQVIA, Medtronic, Medscape/WebMD Global, NovoNordisk: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); SCAI (Women in Innovations Committee Member), Faculty Cardiovascular Research Foundation (CRF), Women as One (Founding Director): SCAI (Women in Innovations Committee Member), Faculty Cardiovascular Research Foundation (CRF), Women as One (Founding Director) (Ongoing)

Speaker(s)

• 

  Megan Coylewright, MD, MPH

  Editor
  American College of Cardiology CardioSmart, Tennessee, United States

  Disclosure(s): Alleviant Medical: Consultant (Ongoing); Boston Scientifiic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Edward Lifesciences: Consultant (Ongoing); Medtronic: Consultant (Ongoing)